These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 32471292)
1. Discovery of a Novel Mutation in DNA Gyrase and Changes in the Fluoroquinolone Resistance of Rhie SY; Park JY; Shin TS; Kim JW; Kim BJ; Kim JG Antibiotics (Basel); 2020 May; 9(6):. PubMed ID: 32471292 [TBL] [Abstract][Full Text] [Related]
2. Mutations of Helicobacter pylori associated with fluoroquinolone resistance in Korea. Lee JW; Kim N; Nam RH; Park JH; Kim JM; Jung HC; Song IS Helicobacter; 2011 Aug; 16(4):301-10. PubMed ID: 21762270 [TBL] [Abstract][Full Text] [Related]
3. Distribution of gyrA mutations in fluoroquinolone-resistant Helicobacter pylori strains. Wang LH; Cheng H; Hu FL; Li J World J Gastroenterol; 2010 May; 16(18):2272-7. PubMed ID: 20458765 [TBL] [Abstract][Full Text] [Related]
4. Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients. Kim JM; Kim JS; Kim N; Jung HC; Song IS J Antimicrob Chemother; 2005 Nov; 56(5):965-7. PubMed ID: 16159928 [TBL] [Abstract][Full Text] [Related]
5. Fluoroquinolone resistance in Helicobacter pylori: role of mutations at position 87 and 91 of GyrA on the level of resistance and identification of a resistance conferring mutation in GyrB. Rimbara E; Noguchi N; Kawai T; Sasatsu M Helicobacter; 2012 Feb; 17(1):36-42. PubMed ID: 22221614 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of primary fluoroquinolone resistance among clinical isolates of Helicobacter pylori at a University Hospital in Southern Taiwan. Hung KH; Sheu BS; Chang WL; Wu HM; Liu CC; Wu JJ Helicobacter; 2009 Feb; 14(1):61-5. PubMed ID: 19191898 [TBL] [Abstract][Full Text] [Related]
7. Resistance of Helicobacter pylori strains to antibiotics in Korea with a focus on fluoroquinolone resistance. Chung JW; Lee GH; Jeong JY; Lee SM; Jung JH; Choi KD; Song HJ; Jung HY; Kim JH J Gastroenterol Hepatol; 2012 Mar; 27(3):493-7. PubMed ID: 21793912 [TBL] [Abstract][Full Text] [Related]
8. Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility. Cattoir V; Nectoux J; Lascols C; Deforges L; Delchier JC; Megraud F; Soussy CJ; Cambau E Int J Antimicrob Agents; 2007 Apr; 29(4):389-96. PubMed ID: 17303392 [TBL] [Abstract][Full Text] [Related]
9. In vitro activity of fluoroquinolone and the gyrA gene mutation in Helicobacter pylori strains isolated from children. Fujimura S; Kato S; Iinuma K; Watanabe A J Med Microbiol; 2004 Oct; 53(Pt 10):1019-1022. PubMed ID: 15358825 [TBL] [Abstract][Full Text] [Related]
10. Primary levofloxacin resistance and gyrA/B mutations among Helicobacter pylori in Japan. Miyachi H; Miki I; Aoyama N; Shirasaka D; Matsumoto Y; Toyoda M; Mitani T; Morita Y; Tamura T; Kinoshita S; Okano Y; Kumagai S; Kasuga M Helicobacter; 2006 Aug; 11(4):243-9. PubMed ID: 16882327 [TBL] [Abstract][Full Text] [Related]
11. Prevalence and mechanisms of resistance to fluoroquinolones in Helicobacter pylori strains from patients living in Belgium. Bogaerts P; Berhin C; Nizet H; Glupczynski Y Helicobacter; 2006 Oct; 11(5):441-5. PubMed ID: 16961806 [TBL] [Abstract][Full Text] [Related]
12. New insights into resistance of Helicobacter pylori against third- and fourth-generation fluoroquinolones: A molecular docking study of prevalent GyrA mutations. Salehi N; Attaran B; Eskini N; Esmaeili M; Sharifirad A; Sadeghi M; Mohammadi M Helicobacter; 2019 Oct; 24(5):e12628. PubMed ID: 31282059 [TBL] [Abstract][Full Text] [Related]
13. Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal. Miftahussurur M; Shrestha PK; Subsomwong P; Sharma RP; Yamaoka Y BMC Microbiol; 2016 Nov; 16(1):256. PubMed ID: 27809767 [TBL] [Abstract][Full Text] [Related]
14. In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV. Yasuda M; Fukuda H; Yokoi S; Ishihara S; Kawada Y; Deguchi T J Urol; 2000 Sep; 164(3 Pt 1):847-51. PubMed ID: 10953166 [TBL] [Abstract][Full Text] [Related]
15. High Efficacy of Finafloxacin on Helicobacter pylori Isolates at pH 5.0 Compared with That of Other Fluoroquinolones. Lee JW; Kim N; Nam RH; Kim JM; Park JY; Lee SM; Kim JS; Lee DH; Jung HC Antimicrob Agents Chemother; 2015 Dec; 59(12):7629-36. PubMed ID: 26416863 [TBL] [Abstract][Full Text] [Related]
16. Acquisition of double mutation in Mori H; Suzuki H; Matsuzaki J; Masaoka T; Kanai T United European Gastroenterol J; 2018 Apr; 6(3):391-397. PubMed ID: 29774152 [TBL] [Abstract][Full Text] [Related]
17. Levofloxacin-resistant Helicobacter pylori in Hong Kong. Lee CC; Lee VW; Chan FK; Ling TK Chemotherapy; 2008; 54(1):50-3. PubMed ID: 18073471 [TBL] [Abstract][Full Text] [Related]
18. High rate of levofloxacin resistance in a background of clarithromycin- and metronidazole-resistant Helicobacter pylori in Vietnam. Phan TN; Santona A; Tran VH; Tran TN; Le VA; Cappuccinelli P; Rubino S; Paglietti B Int J Antimicrob Agents; 2015 Mar; 45(3):244-8. PubMed ID: 25499186 [TBL] [Abstract][Full Text] [Related]
19. Mechanism of quinolone resistance in Staphylococcus aureus. Tanaka M; Wang T; Onodera Y; Uchida Y; Sato K J Infect Chemother; 2000 Sep; 6(3):131-9. PubMed ID: 11810552 [TBL] [Abstract][Full Text] [Related]
20. Mutant prevention concentrations for single-step fluoroquinolone-resistant mutants of wild-type, efflux-positive, or ParC or GyrA mutation-containing Streptococcus pneumoniae isolates. Smith HJ; Walters M; Hisanaga T; Zhanel GG; Hoban DJ Antimicrob Agents Chemother; 2004 Oct; 48(10):3954-8. PubMed ID: 15388458 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]